Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.82 USD | +3.12% | +10.28% | +201.90% |
05-20 | Transcript : Jasper Therapeutics, Inc. - Special Call | |
05-13 | Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+201.90% | 348M | |
+37.74% | 723B | |
+32.22% | 598B | |
-2.07% | 364B | |
+20.25% | 331B | |
+2.99% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+7.43% | 169B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Credit Suisse Lowers Jasper Therapeutics' PT to $3 From $7 After Announcing Pipeline Reprioritization, Keeps Outperform Rating